Aslan Pharmaceuticals: Case Study of a Start-up in Singapore
Hosted By : Niamh MadiganAugust 8, 2012
Rate this Podcast:
(Be the First!)
About this Podcast...
Most big pharma are now setting up operations in Asia, with China predicted to be the biggest market in pharmaceuticals by 2025. Mark McHale, Chief Scientific Officer at Aslan Pharmaceuticals discusses the set up of the pharma organisation in Singapore over two years ago, looking at the advantages and indeed challenges of operating in the East and the opportunities that lie ahead certainly from 2020 on.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Rate this Podcast:
(Be the First!)
Events of Interest
-
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem
April 4, 2013
Register Now -
Guarantee GDP- Compliant Cool Chain Logistics for Pharmaceuticals to CEE & CIS Countries
January 16, 2013
Register Now -
Using Social Media to Drive Product Sales and Grow your Brand
June 28, 2012
Register Now -
Digitalise your Business Development and Lead Generation Strategy
June 26, 2012
Register Now





Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!